Retatrutide has emerged as a new medication in the fight against obesity. This novel drug, classified as a dual GLP-1 and GIP receptor agonist, exhibits promising results in investigations. By activating these https://katrinamvii359107.blogocial.com/tirzepatide-a-promising-new-treatment-for-obesity-71881221